112204-57-6

Basic information

• Product Name: 5-BROMO-2-FLUOROBENZENEBORONIC ACID 98
• Synonyms: 5-Bromo-2-fluorophenylboronic acid;(5-Bromo-2-fluorophenyl)boronic acid;5-BROMO-2-FLUOROBENZENEBORONIC ACID 98;5-Bromo-2-fluorobenzeneboronic acid;5-Bromo-2-fluorobenzeneboronic acid 98%;5-Bromo-2-fluorophenylboronic Acid (contains varying amounts of Anhydride)
• CAS NO: 112204-57-6
• Molecular Formula: C₆H₅BBrFO₂
• Molecular Weight: 218.8161032
• Product Categories: Aryl;Boronic Acids;Boronic Acids and Derivatives;blocks;BoronicAcids
• Mol File: 112204-57-6.mol

Chemical Properties

• Melting Point: 144-149 °C(lit.)
• Boiling Point: 324.831 °C at 760 mmHg
• Flash Point: 150.252 °C
• Appearance: off-white solid
• Density: 1.75 g/cm³
• Storage Temp.: Keep Cold
• PKA: 7.35±0.58(Predicted)
• CAS DataBase Reference: 5-BROMO-2-FLUOROBENZENEBORONIC ACID 98(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BROMO-2-FLUOROBENZENEBORONIC ACID 98(112204-57-6)
• EPA Substance Registry System: 5-BROMO-2-FLUOROBENZENEBORONIC ACID 98(112204-57-6)

Safety Data

• Hazard Codes: Xi
• WGK Germany: 3
• HazardClass: IRRITANT, KEEP COLD
• Hazardous Substances Data: 112204-57-6(Hazardous Substances Data)

Usage

Uses

suzuki reaction

Upstream product

• 768-66-1 2,2,6,6-tetramethyl-piperidine 
• 460-00-4 1-Bromo-4-fluorobenzene 
• 121-43-7 Trimethyl borate 
• 2369-37-1 1,2,-dibromo-4-fluorobenzene 
• 1435-53-6 2,4-dibromo-1-fluorobenzene 
• 5419-55-6 Triisopropyl borate 

Downstream Products

• 112204-58-7 5-Bromo-2-fluorophenol 
• 865186-62-5 2-bromo-4-fluoro-5-methoxylbenzaldehyde 
• 861928-19-0 4,5-dibromo-2-fluoroanisole 
• 943917-47-3 (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[5'-bromo-2'-fluoro-4-(trifluoromethyl)-biphenyl-2-yl]methyl}-4-methyl-1,3-oxazolidin-2-one 
• 1346146-72-2 (R)-4-(5-bromo-2-fluorophenyl)-4-methyloxazolidin-2-one 

Relevant articles and documents

PHENYLGLYCINAMIDE DERIVATIVES USEFUL AS ANTICOAGULANTS

The present invention relates generally to phenylglycinamide derivatives that inhibit serine proteases. In particular it is directed to novel phenylglycinamide derivatives, and analogues thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.

MIDAZOPYRAZINONES AND IMIDAZOTRIAZINONES DERIVATES AS GABA-A RECEPTOR ANXIOLYTIC

The present invention discloses a compound of formula I, or a pharmaceutically acceptable salt thereof: (I) wherein -U-V- represents -CH=CH-, or -CH2-CH2-, -N=CH- or -CH=N-; X1 represents hydrogen, halogen, C1-6 alkyl, trifluoromethyl or C1-6 alkoxy; X2 represents hydrogen or halogen; Y represents a chemical bond, an oxygen atom, or a -NH- or -OCH2- linkage; Z represents an optionally substituted aryl or heteroaryl group; R1 represents hydrocarbon, a heterocyclic group, trifluoromethyl, -SO2Ra, -SO2NRaRb, -CORa, -CO2Ra or -CONRaRb; and Ra and Rb independently represent hydrogen, hydrocarbon or a heterocyclic group;pharmaceutical compositions comprising it; its use in methods of treatment; use of it in the manufacture of a medicament for treating and/or preventing anxiety; convulsions or a cognitive disorder; and methods of treatment using it.

IMIDAZO-PYRIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS

A class of 8-fluoro-3-phenylimidazo[1,2-a]pyridine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group, or by a pyrrolidinonyl group, which is directly attached or bridged by an oxygen atom or by a -NH- or -OCH2- linkage, being selective ligands for GABAA receptors, in particular having high affinity for the α2 and/or α3 and/or α5 subunit thereof, are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.

Process for the preparation of 5-bromo-2-fluorobenzeneboronic acid

A process is disclosed for the preparation of 5-bromo-2-fluorobenzeneboronic acid, which is useful as an intermediate in the preparation of a non-ester pyrethroid compound. The compound can be, for example, a fluoroolefin, which is useful as a pesticide.

Intermediates useful in the production of pesticides

A process for the production of a boronic acid of formula III, STR1 in which an organometallic of formula IV, STR2 in which formula IV, M represents a metallic moiety such as --MgX, X being a halogen or an alkali metal is treated with a trialkoxy borane of formula B(OR)3, R representing an alkyl group and the product is hydrolyzed.